000760108 000__ 04629cam\a2200493Ii\4500
000760108 001__ 760108
000760108 005__ 20230306141952.0
000760108 006__ m\\\\\o\\d\\\\\\\\
000760108 007__ cr\cn\nnnunnun
000760108 008__ 160819s2016\\\\sz\a\\\\o\\\\\000\0\eng\d
000760108 019__ $$a957597568
000760108 020__ $$a9783319403892$$q(electronic book)
000760108 020__ $$a3319403893$$q(electronic book)
000760108 020__ $$z9783319403878
000760108 020__ $$z3319403877
000760108 035__ $$aSP(OCoLC)ocn956988848
000760108 035__ $$aSP(OCoLC)956988848$$z(OCoLC)957597568
000760108 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dIDEBK$$dEBLCP$$dGW5XE$$dOCLCO$$dYDX$$dOCLCF$$dOCLCO
000760108 049__ $$aISEA
000760108 050_4 $$aRC280.L8
000760108 08204 $$a616.99/42406$$223
000760108 08204 $$a610
000760108 24500 $$aLung cancer$$h[electronic resource] :$$btreatment and research /$$cKaren L. Reckamp, editor.
000760108 264_1 $$aSwitzerland :$$bSpringer,$$c2016.
000760108 300__ $$a1 online resource (vi, 322 pages) :$$billustrations.
000760108 336__ $$atext$$btxt$$2rdacontent
000760108 337__ $$acomputer$$bc$$2rdamedia
000760108 338__ $$aonline resource$$bcr$$2rdacarrier
000760108 4901_ $$aCancer treatment and research ;$$vvolume 170
000760108 5050_ $$a1 Lung Cancer Screening; Abstract; 1 Why Screen for Lung Cancer?; 2 Screening with Chest X-Ray and Sputum Cytologic Studies; 3 Screening with Low-Dose CT of the Chest; 4 Benefits and Risks of LDCT Screening; 5 Guidelines for LDCT Screening; 6 Conclusions; References; 2 Diagnosis and Molecular Classification of Lung Cancer; Abstract; 1 Introduction; 2 Histological Classification of NSCLC; 2.1 Adenocarcinoma (ADC); 2.2 Squamous Cell Carcinoma (SqCC); 2.3 Large-Cell Lung Carcinoma (LCLC); 3 Molecular Alterations of NSCLC; 3.1 Epidermal Growth Factor Receptor (EGFR)
000760108 5058_ $$a3.2 Anaplastic Lymphoma Kinase (ALK)3.3 Human Epidermal Growth Factor Receptor 2 (HER2); 3.4 ROS Proto-Oncogene 1, Receptor Tyrosine Kinase (ROS); 3.5 Ret Proto-Oncogene (RET); 3.6 NTRK1 (TrkA) Fusions; 3.7 MET; 3.8 Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS); 3.9 B-Raf Proto-Oncogene, Serine/Threonine Kinase (BRAF); 3.10 Neuroblastoma RAS Viral (V-Ras) Oncogene Homolog (NRAS); 3.11 v-AKT Murine Thymoma Viral Oncogene Homolog 1 (AKT1); 3.12 Mitogen-Activated Protein Kinase 1 (MAP2K1); 3.13 Phosphatidylinositol-4,5-Bisphosphate 3-Kinase, Catalytic Subunit Alpha (PIK3CA)
000760108 5058_ $$a4 Diagnostic and Molecular Testing of NSCLC4.1 Pathological Diagnosis of NSCLC; 4.1.1 Thyroid Transcription Factor 1 (TTF-1); 4.1.2 p40; 4.1.3 Mucicarmin; 4.2 Molecular Testing of NSCLC; 5 Future Directions: Immunotherapy Revolution and Its Integration with Lung Cancer Diagnostics and Therapy; 6 Conclusions; References; 3 Lung Cancer Staging and Prognosis; Abstract; 1 Lung Cancer Overview; 2 Lung Cancer Staging; 2.1 History of Lung Cancer Staging; 2.2 Non-small Cell Lung Cancer Staging; 2.2.1 IALSC NSCLC TNM Descriptors; 2.2.2 Synchronous Tumor Nodules; 2.3 Pulmonary Carcinoid Tumor Staging
000760108 5058_ $$a2.4 Small Cell Lung Cancer Staging3 Prognosis; 3.1 Stage-Based Survival Outcomes; 3.2 Clinical and Demographic Prognostication; 3.3 Biomarkers and Genetic Prognostic Indicators; 3.4 Predictive Biomarkers; 3.5 Immunotherapy and Prognosis; 3.6 The Future of NSCLC Prognostication; References; 4 Surgical Treatment of Lung Cancer; Abstract; 1 Introduction; 2 Preoperative Evaluation; 2.1 Radiographic Staging; 2.2 Tissue Diagnosis; 2.3 Physiologic Pulmonary Evaluation; 2.4 Cardiac Evaluation; 2.5 Mediastinal Staging; 3 Surgery and Small-Cell Lung Cancer (SCLC); 4 Non-Small-Cell Lung Cancer (NSCLC)
000760108 5058_ $$a4.1 Stage IA4.2 Stage IB; 4.3 Stage IIB; 4.4 Stage III NSCLC; 4.4.1 Stage IIIA (e.g., T3N1/T4N1); 4.4.2 Stage IIIA with N2 Disease; 4.5 Stage IIIB and IV NSCLC; 4.6 Special Situations; 4.6.1 Extended Resections; 4.6.2 Synchronous NSCLC; 4.6.3 Oligometastatic Disease; 5 Surgical Options and Approaches; 5.1 Types of Incisions; 5.2 Types of Surgical Resection; 5.2.1 Wedge Resection; 5.2.2 Segmentectomy; 5.2.3 Lobectomy; 5.2.4 Pneumonectomy; 5.2.5 Sleeve Resections; 5.2.6 Carinal Resection; 6 Summary; Bibliography; 5 Treatment: Radiation Therapy; Abstract; 1 Stage I-II Disease
000760108 506__ $$aAccess limited to authorized users.
000760108 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed August 29, 2016).
000760108 650_0 $$aLungs$$xCancer$$xTreatment.
000760108 7001_ $$aReckamp, Karen L.,$$eeditor.
000760108 77608 $$iPrint version:$$z9783319403878$$z3319403877$$w(OCoLC)950953348
000760108 830_0 $$aCancer treatment and research ;$$vvolume 170.
000760108 852__ $$bebk
000760108 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-40389-2$$zOnline Access$$91397441.1
000760108 909CO $$ooai:library.usi.edu:760108$$pGLOBAL_SET
000760108 980__ $$aEBOOK
000760108 980__ $$aBIB
000760108 982__ $$aEbook
000760108 983__ $$aOnline
000760108 994__ $$a92$$bISE